Summit Global Investments Harmony Biosciences Holdings, Inc. Transaction History
Summit Global Investments
- $1.57 Billion
- Q3 2024
A detailed history of Summit Global Investments transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Summit Global Investments holds 19,263 shares of HRMY stock, worth $618,920. This represents 0.05% of its overall portfolio holdings.
Number of Shares
19,263
Previous 20,164
4.47%
Holding current value
$618,920
Previous $608,000
26.81%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
225Shares Held
45MCall Options Held
48.2KPut Options Held
56.5K-
Valor Management LLC Chicago, IL11.2MShares$360 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$187 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$113 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$83.7 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$80.6 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.9B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...